Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
Corominas H, Castellví I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Millán AM, Quijada MÁ, Puig M, Casademont J, Domingo P.
Corominas H, et al. Among authors: antonijoan r.
Clin Immunol. 2021 Feb;223:108631. doi: 10.1016/j.clim.2020.108631. Epub 2020 Nov 12.
Clin Immunol. 2021.
PMID: 33189888
Free PMC article.